Lincoln Pharmaceuticals Limited has intimated the National Stock Exchange of India Limited (NSE) and BSE Limited about an upcoming Board of Directors meeting scheduled for Thursday, 29th October, 2026.
The Board will consider the following agenda items:
- Approval of unaudited financial results (both standalone and consolidated) for the quarter and half year ended on September 30, 2026
- Any other business with the permission of the Chairman
In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, the company's trading window for securities has been closed since October 1, 2026. The trading window will reopen after 48 hours from the time the financial results become generally available to the public.
The communication was signed by Trusha Shah, Company Secretary & Compliance Officer, from the company's registered office at "Lincoln House", Science City Road, Sola, Ahmedabad-380 060, Gujarat, India.